Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Capital Reinvestment Ratio
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Capital Reinvestment Ratio of 0.52x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥58.54 Million) in capital expenditures (CN¥30.63 Million). Check how tangible is Sichuan Huiyu Pharmaceutical Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sichuan Huiyu Pharmaceutical Co Ltd Capital Reinvestment Ratio (2018–2024)
This chart tracks Sichuan Huiyu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see how efficiently does Sichuan Huiyu Pharmaceutical Co Ltd generate cash.
Annual Capital Reinvestment Ratio for Sichuan Huiyu Pharmaceutical Co Ltd (2018–2024)
Year-by-year Capital Reinvestment Ratio for Sichuan Huiyu Pharmaceutical Co Ltd from 2018 to 2024. See Sichuan Huiyu Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.53x | CN¥242.96 Million | CN¥128.18 Million | ▼ -88.1% |
| 2023 | 4.43x | CN¥66.93 Million | CN¥296.72 Million | ▲ +86.4% |
| 2022 | 2.38x | CN¥194.06 Million | CN¥461.61 Million | ▲ +145.0% |
| 2021 | 0.97x | CN¥446.36 Million | CN¥433.45 Million | ▲ +138.1% |
| 2020 | 0.41x | CN¥387.95 Million | CN¥158.24 Million | ▲ +21.0% |
| 2019 | 0.34x | CN¥326.22 Million | CN¥110.00 Million | ▲ +88.9% |
| 2018 | 0.18x | CN¥129.06 Million | CN¥23.04 Million | — |